Form 4 for RKLB Rocket Lab Corp
Accepted 2025-11-25 00:00:00 ET · period of report 2025-11-22 · accession 0002001011-25-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-25 | 2025-11-22+ | RKLB | Spice Adam C. | CFO | S - Sale | $40.65 | -62.6K | 2.00M | -3% | -$2.55M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-22 | S | D | 15,633 | $40.02 | 2,042,367 | D | — | — | (F1) Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person. (F2) The price reported in column 4 is a weighted average price of the aggregate number of shares. These shares were sold in multiple transactions in bulk at prices ranging from $39.3400 to $40.3300 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Includes 111 shares acquired under the Rocket Lab Corporation 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 2 | Common | Common Stock | 2025-11-24 | S | D | 257 | $41.35 | 1,995,373 | D | — | — | (F1) Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person. (F5) The price reported in column 4 is a weighted average price of the aggregate number of shares. These shares were sold in multiple transactions in bulk at prices ranging from $41.3400 to $41.4200 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Includes 111 shares acquired under the Rocket Lab Corporation 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
| 3 | Common | Common Stock | 2025-11-24 | S | D | 46,737 | $40.86 | 1,995,630 | D | — | — | (F1) Represents the sale of Common Shares pursuant to a "sell-to-cover" transaction in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the reporting person. (F4) The price reported in column 4 is a weighted average price of the aggregate number of shares. These shares were sold in multiple transactions in bulk at prices ranging from $40.3400 to $41.3300 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F3) Includes 111 shares acquired under the Rocket Lab Corporation 2021 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |